
Natera wins $19.3 million in damages in a patent infringement case against ArcherDX for cancer detection technology.


coremsg

Genetic testing company Natera Inc convinced a Delaware federal jury on Monday to award it $19.3 million in damages from Invitae Corp's ArcherDX for infringing patents related to cancer detection.

Natera Wins US Verdict in Cancer-Detection Patent Case

natera-wins-19-3-million-in-cancer-detection-patent-case-against-archerdx


Natera Wins $19.3 Million in Cancer-Detection Patent Case Against ArcherDX
